Cited by 712Health Policy Implementation ScienceHealth Sciences Research and EducationClinical practice guidelines implementation

Tailored interventions to address determinants of practice

Open access
Baker, Richard, Camosso-Stefinovic, Janette, Gillies, Clare, Shaw, Elizabeth J, Cheater, Francine, Flottorp, Signe, Robertson, Noelle, Wensing, Michel +5 more·2015·Cochrane Database of Systematic Reviews

Abstract

BACKGROUND: Tailored intervention strategies are frequently recommended among approaches to the implementation of improvement in health professional performance. Attempts to change the behaviour of health professionals may be impeded by a variety of different barriers, obstacles, or factors (which we collectively refer to as determinants of practice). Change may be more likely if implementation strategies are specifically chosen to address these determinants. OBJECTIVES: To determine whether tailored intervention strategies are effective in improving professional practice and healthcare outcomes. We compared interventions tailored to address the identified determinants of practice with either no intervention or interventions not tailored to the determinants. SEARCH METHODS: We conducted searches of The Cochrane Library, MEDLINE, EMBASE, PubMed, CINAHL, and the British Nursing Index to May 2014. We conducted a final search in December 2014 (in MEDLINE only) for more recently published trials. We conducted searches of the metaRegister of Controlled Trials (mRCT) in March 2013. We also handsearched two journals. SELECTION CRITERIA: Cluster-randomised controlled trials (RCTs) of interventions tailored to address prospectively identified determinants of practice, which reported objectively measured professional practice or healthcare outcomes, and where at least one group received an intervention designed to address prospectively identified determinants of practice. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed quality and extracted data. We undertook qualitative and quantitative analyses, the quantitative analysis including two elements: we carried out 1) meta-regression analyses to compare interventions tailored to address identified determinants with either no interventions or an intervention(s) not tailored to the determinants, and 2) heterogeneity analyses to investigate sources of differences in the effectiveness of interventions. These included the effects of: risk of bias, use of a theory when developing the intervention, whether adjustment was made for local factors, and number of domains addressed with the determinants identified. MAIN RESULTS: We added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants. The outcome was implementation of recommended practice, e.g. clinical practice guideline recommendations. Fifteen studies provided enough data to be included in the quantitative analysis. The pooled odds ratio was 1.56 (95% confidence interval (CI) 1.27 to 1.93, P value < 0.001). The 17 studies not included in the meta-analysis had findings showing variable effectiveness consistent with the findings of the meta-regression. AUTHORS' CONCLUSIONS: Despite the increase in the number of new studies identified, our overall finding is similar to that of the previous review. Tailored implementation can be effective, but the effect is variable and tends to be small to moderate. The number of studies remains small and more research is needed, including trials comparing tailored interventions to no or other interventions, but also studies to develop and investigate the components of tailoring (identification of the most important determinants, selecting interventions to address the determinants). Currently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants. It is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be.

Verified 2026-10-06 · 1 reference not checked yet

AI snapshot

Written from the paper’s full text.

TL;DR

This updated Cochrane review found that tailored implementation interventions can improve professional practice, but effects are variable and small to moderate. Across 15 studies in meta-regression, the pooled odds ratio was 1.56 (95% CI 1.27 to 1.93, P < 0.001).

Key findings

  • The review included 32 cluster-randomised trials comparing tailored interventions with no intervention or non-tailored interventions; 15 studies contributed to the meta-regression, with a pooled OR of 1.56 (95% CI 1.27 to 1.93, P < 0.001).
  • In separate comparisons, tailored versus no intervention had a pooled OR of 1.36 (95% CI 0.92 to 1.99, P = 0.099) across 7 studies, while tailored versus non-tailored intervention had a pooled OR of 1.79 (95% CI 1.06 to 3.01, P = 0.033) across 8 studies; removing Beeckman 2013 gave OR 1.48 (95% CI 1.24 to 1.75, P = 0.002).
  • The 17 studies not included in the meta-analysis showed variable effectiveness consistent with the meta-regression; GRADE certainty was moderate, and there were insufficient data to assess healthcare outcomes, costs, or adverse effects.
  • Heterogeneity analyses found no association between effectiveness and risk of bias, use of theory, adjustment for local factors, or number of determinant domains addressed.

Methods

  • Updated Cochrane review of cluster-RCTs with at least two control and two intervention sites, including healthcare professionals responsible for patient care; tailored interventions were defined as strategies planned after prospective identification of determinants of practice.
  • Searches covered The Cochrane Library, MEDLINE, EMBASE, PubMed, CINAHL, and the British Nursing Index to May 2014, with a final MEDLINE search in December 2014; 9403 unique citations were screened and 32 studies included.
  • Two review authors independently assessed quality and extracted data; meta-regression combined adjusted odds ratios with baseline odds ratios as a covariate, and heterogeneity was investigated using the I² residual statistic.

Limitations

  • The paper states that the number of studies remains small, methods of tailoring are not well developed or described, it is unclear which element of tailored strategies explains effectiveness, and cost-effectiveness is uncertain.
  • The paper states that only 15 of 32 trials could be included in the meta-regression, limiting power to detect study attributes explaining variation, and that evidence is limited for low-income countries and disadvantaged groups.
  • Evident from the text: risk of bias was high in 4 studies and unclear in 21, most control groups received only guidelines or educational materials, and no included studies provided sufficient evidence on healthcare outcomes, costs, or adverse effects.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/14651858.cd005470.pub3

Cites

223 of 224 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 194 cited sources checked · 0 supported · 0 flagged

  • Findingown data
    § Background

    No reviews other than earlier versions of this review have evaluated the effects of tailored implementation strategies on professional performance.

    “We have not identified any reviews evaluating the effects of tailored implementation strategies on professional performance other than the earlier versions of this review”
    Quote in the paperSubstantial claim
  • Findingown data
    § Methods

    Five studies included in the analysis reported either an estimate of the ICC or reported data for each cluster, allowing the ICC to be estimated.

    “Five studies included in the analysis reported either an estimate of the ICC or reported data for each cluster, allowing the ICC to be estimated.”
    Quote in the paperSubstantial claim
  • Findingown data
    § Results

    For the seven studies that received no control intervention, the pooled odds ratio was 1.36 (95% CI 0.92 to 1.99, P = 0.099).

    “Of these, seven were suitable for inclusion in a meta‐regression, and the pooled odds ratio for the seven studies that received no control intervention was 1.36 (95% CI 0.92 to 1.99, P value = 0.099) (Avorn 1992; Callahan 1994; Flottorp 2002; Looijmans 2010; Murphy 2009; Scott 2013; Schouten 2007).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Avorn 1992 source

      Not checked in the free run.

    • cites Callahan 1994 source

      Not checked in the free run.

    • cites Flottorp 2002 source

      Not checked in the free run.

  • Findingcitation
    § Data synthesis

    One study delivered a group lecture and distributed the standard protocol to the control group.

    “One study delivered a group lecture and distributed the standard protocol to the control group (Beeckman 2013).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Beeckman 2013 source

      Not checked in the free run.

  • Findingown data
    § Abstract

    Fifteen studies provided enough data to be included in the quantitative analysis.

    “Fifteen studies provided enough data to be included in the quantitative analysis.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. 187
  • May combine two claims. 29
  • The quote only partly states this claim. 2
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data
    § Results

    Seven included studies are ongoing and seven are awaiting assessment.

    “Seven are ongoing studies (Ongoing studies) and seven are awaiting assessment (Studies awaiting classification).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Results

    The remaining 17 studies were not eligible for meta-regression because they either did not assess a suitable binary outcome or reported no data at baseline.

    “The remaining 17 studies were not eligible for meta‐regression because they either did not assess a suitable binary outcome, or they reported no data at baseline.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingcitation
    § Discussion

    In this update, we identified an additional nine studies, seven of which had been published since the previous version of the review.

    “In this update of our review of randomised trials of tailored implementation interventions, we identified an additional nine studies, seven of which had been published since the previous version of the review (Baker 2010).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Baker 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data
    § Results

    Twenty-three of the included studies had been included in the previous version of the review, but three studies from that review were excluded because their interventions were not assessed as meeting the criteria for tailoring.

    “Twenty‐three of the studies had been included in the previous version of the review, but we excluded three studies from that review because the interventions were not assessed on this occasion as meeting the criteria for tailoring (Davies 2002; Sehgal 2002; Verhoeven 2005).”
    Quote in the paperNot a substantial claim0 of 3 sources checked
    • cites Davies 2002

      Not checked in the free run.

    • cites Sehgal 2002 source

      Not checked in the free run.

    • cites Verhoeven 2005 source

      Not checked in the free run.

  • May combine two claims.

    Findingown data
    § Results

    None of the assessed study attributes (risk of bias, explicit use of theory, adjustment to local factors, number of domains addressed) were found to be associated with the reported effectiveness of tailored interventions.

    “Separate models were fitted dependent on the intervention delivered to the control group (none or non‐tailored), but none were found to be associated with the reported effectiveness of the tailored interventions.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § Results

    We included 15 of 32 studies in the meta-regression analysis.

    “We included 15 of 32 studies in the meta‐regression analysis (Table 2; Table 3).”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Findingnone given
    § Abstract

    We added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants.

    “We added nine studies to this review to bring the total number of included studies to 32 comparing an intervention tailored to address identified determinants of practice to no intervention or an intervention(s) not tailored to the determinants.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data
    § Results

    We screened 9403 unique citations and reviewed the full text of 360.

    “We screened 9403 unique citations (Figure 1) and reviewed the full text of 360.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Discussion

    Our overall finding is similar to that of the previous review.

    “Despite the increase in the number of studies, however, our overall finding is similar to that of the previous review.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Results

    Clear reports of unintended effects of implementation interventions were not included in the studies.

    “Clear reports of such effects were not included in the studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data
    § Results

    We excluded 106 studies with reasons and 208 with quick reference to the full text.

    “We excluded 106 with reasons provided in the Characteristics of excluded studies table and we excluded 208 with quick reference to the full text.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Abstract

    The 17 studies not included in the meta-analysis had findings showing variable effectiveness consistent with the findings of the meta-regression, varying from no effect to moderate effect between studies and between outcomes within studies.

    “The 17 studies not included in the meta‐analysis had findings showing variable effectiveness consistent with the findings of the meta‐regression.”
    • Also stated in: § Summary of findings · plain
      “The effect of tailored interventions in these studies varied from no effect to moderate effect between studies and between outcomes within studies, a finding consistent with the meta‐regression”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingnone given
    § Authors' conclusions

    Currently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants.

    “Currently available studies have used different methods to identify determinants of practice and different approaches to selecting interventions to address the determinants.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § Methods

    Where data were collected on the same group of patients throughout the trial (three studies), no problem with drop-outs was reported.

    “Where data were collected on the same group of patients throughout the trial (three studies), no problem with drop‐outs was reported.”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Findingown data
    § Results

    In sensitivity analyses using higher ICC estimates, the pooled odds ratio for all 15 studies was 1.54 (95% CI 1.27 to 1.86, P < 0.001).

    “For the main analysis with all 15 studies, the pooled odds ratio was 1.54 (95% CI 1.27 to 1.86, P value < 0.001).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingreasoning
    § Methods

    The majority of trials included in this review collected data before and after interventions on different patients, therefore drop-out at the patient level was not an issue for these trials.

    “The majority of trials included in this review collected data before and after interventions on different patients, therefore drop‐out at the patient level was not an issue for these trials.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Findingnone given
    § Authors' conclusions

    It is not possible to determine from the studies reviewed which methods of identifying determinants and tailoring interventions to account for them should be selected.

    “Also, it is not possible to determine from the studies reviewed which methods of identifying determinants and tailoring interventions to account for them should be selected.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingcitation
    § Certainty of the evidence

    The previous version of the review included 26 trials.

    “26 were included in the previous version (Baker 2010)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Baker 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Findingnone given
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In some studies, adjustments were made at the level of the cluster (clinical team, hospital).

    “Whether adjustment was made for local factors New In some studies, adjustments were made at the level of the cluster (clinical team, hospital), and these adjustments could potentially improve the intervention effect Add”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § Certainty of the evidence

    Three studies included in the previous version were excluded from this update because they were assessed as no longer meeting criteria for tailoring.

    “We excluded three studies from this update that had been included in the previous version of the review because we assessed them as no longer meeting our criteria for tailoring.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given

    The studies employed various interventions to improve professional practice.

    “The studies employed various interventions to improve professional practice”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    There were insufficient data in the included studies to assess healthcare outcomes, costs, and adverse events.

    “Outcome: Healthcare outcomes Cluster‐RCTs Insufficient data in the included studies Outcome: Costs Cluster‐RCTs Insufficient data in the included studies Outcome: Adverse events Cluster‐RCTs Insufficient data in the included studies”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingnone given
    § Discussion

    In the included studies, tailoring was undertaken in different ways and agreement on which methods should be used appeared to be absent.

    “In the included studies, tailoring was undertaken in different ways and agreement on which methods should be used appeared to be absent.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingreasoning
    § Agreements and disagreements with other studies and reviews

    The methods of tailoring are not yet well developed and are not described in detail in published studies.

    “the methods of tailoring are not yet well developed and are not described in detail in published studies.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingnone given
    § Certainty of the evidence

    It was possible to include 32 trials in this update.

    “It was possible to include 32 trials in this update”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data
    § What's new

    Nine new studies were identified and added in this update.

    “New searches performed to December 2014 and nine new studies identified”
    • Also stated in: § What's new · plain
      “We excluded three studies from the previous version of the review and added nine studies in this update, giving 32 studies in total.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    The new search for studies and content updated did not change the conclusions.

    “New search for studies and content updated (no change to conclusions)”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingnone given
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In this update, three studies were excluded from the previous version of the review and nine studies were added, giving 32 studies in total.

    “We excluded three studies from the previous version of the review in this update, and added nine studies, giving 32 studies in total.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation
    § Background

    Reviews in specific clinical fields discussed the possibility that tailored strategies might be more effective than strategies selected without taking account of determinants, but did not address the effect or costs of tailored interventions specifically.

    “Although there are a number of reviews in specific clinical fields (Chaillet 2006; Kroenke 2000), which have discussed the possibility that tailored strategies might be more effective than strategies selected without taking account of determinants, these reviews did not address the effect or costs of tailored interventions specifically.”
    Quote in the paperSubstantial claim0 of 2 sources checked
    • cites Chaillet 2006 source

      Not checked in the free run.

    • cites Kroenke 2000 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisenone given
    § Background

    Earlier versions of this review concluded that tailored interventions were more likely to improve professional practice than no intervention or dissemination of guidelines or educational materials alone.

    “which concluded that tailored interventions were more likely to improve professional practice than no intervention or dissemination of guidelines or educational materials alone.”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Premisereasoning
    § Abstract

    Determinants of practice can impede attempts to change health professional behaviour and are believed to influence the success of improvement strategies.

    “Attempts to change the behaviour of health professionals may be impeded by a variety of different barriers, obstacles, or factors (which we collectively refer to as determinants of practice).”
    • Also stated in: § Background · hedged
      “determinants are believed to influence the success of improvement strategies.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Background

    There can be delays before the findings of research are widely adopted.

    “there can be delays before the findings of research are widely adopted”
    Quote in the paperNot a substantial claim0 of 2 sources checked
    • cites Grol 2005

      Not checked in the free run.

    • cites Oxman 1995

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning
    § Background

    If determinants of practice are identified and strategies are implemented that have been chosen to address them, it is reasonable to expect performance to improve.

    “it would appear reasonable to expect performance to improve”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning
    § Discussion

    The unexpected finding of a smaller effect compared with no intervention may be due to imprecision, chance, the small number of studies, and other unexplained factors.

    “This unexpected finding may be due to imprecision, chance, the small number of studies, and other unexplained factors.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Methods

    Two review authors independently classified the intensity of the methods used to identify determinants.

    “Two review authors independently classified the intensity of the methods used to identify determinants using the following three categories”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning
    § Authors' conclusions

    It is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be; there is insufficient evidence on the most effective approaches to tailoring, including identification of determinants, prioritisation, and selection of interventions.

    “It is not yet clear how best to tailor interventions and therefore not clear what the effect of an optimally tailored intervention would be.”
    • Also stated in: § Plain language summary · plain
      “There is insufficient evidence on the most effective approaches to tailoring, including how determinants should be identified, how decisions should be made on which determinants are most important to address, and how interventions should be selected to account for the important determinants.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Assessment of reporting biases

    Meta-regression was used in the analyses to account for differences between control and intervention groups at study baselines.

    “In our analyses, we used meta‐regression in order to be able to account for differences between control and intervention groups at study baselines.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given
    § Assessment of reporting biases

    No language restrictions were applied in the searches or inclusion of studies.

    “We applied no language restrictions in the searches or inclusion of studies.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given
    § Assessment of reporting biases

    A sensitive search of major biomedical databases and trial registries was conducted.

    “We conducted a sensitive search of major biomedical databases and trial registries (see Search methods for identification of studies).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Methods

    Two review authors independently extracted the data from included studies.

    “Two review authors independently extracted the data from included studies by using a revised version of the data extraction form used in the previous version of the review (Baker 2010).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Baker 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Methods

    Two review authors assessed the risk of bias of the included studies using the Cochrane Handbook approach.

    “Two review authors assessed the risk of bias of the included studies using the approach set out in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Higgins 2011

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Interpretationreasoning
    § Results

    Adverse effects of implementation interventions may have been unlikely, although unintended effects are possible.

    “Since the studies were of interventions designed to implement appropriate clinical practice, adverse effects may have been unlikely, although it is possible that the implementation interventions could have unintended effects.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Methods

    Two review authors independently assessed studies for inclusion.

    “Two review authors independently assessed studies for inclusion.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim. May combine two claims.

    Study design and conductcitation
    § Data synthesis

    For the 15 studies included in the meta-regression, estimated odds ratios for each study (adjusted for clustering) were combined using meta-regression techniques, with baseline odds ratios included as a covariate to adjust for baseline differences between intervention and control groups.

    “For the 15 studies included in the meta‐regression, we combined the estimated odds ratios for each study (adjusted for clustering) using meta‐regression techniques, whereby the baseline odds ratios were included as a covariate to adjust for any baseline differences between the intervention and control groups (Sutton 2000).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Sutton 2000

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Methods

    Two independent review authors classified the extent to which the tailored intervention was adjusted to account for local factors.

    “Two independent review authors classified the extent to which the tailored intervention was adjusted to account for local factors using the following two categories”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Background

    Bosch and colleagues undertook a qualitative analysis of 20 quality improvement studies reporting investigation of determinants.

    “Bosch and colleagues undertook a qualitative analysis of 20 quality improvement studies reporting investigation of determinants (Bosch 2007).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Bosch 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Methods

    Heterogeneity for all meta-regression models was assessed using the I2 residual statistic, which represents the proportion of residual between-study variation due to heterogeneity rather than sampling variability.

    “We assessed heterogeneity for all meta‐regression models using the I² residual statistic (Higgins 2003), which represents the proportion of residual between‐study variation due to heterogeneity, as opposed to sampling variability.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Higgins 2003 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisereasoning
    § Assessment of reporting biases

    There is no equivalent of forest or funnel plots for meta-regression analyses, and reliance on only follow-up results to produce such plots would have provided misleading information.

    “There is no equivalent of forest or funnel plots for meta‐regression analyses and reliance on only follow‐up results to produce such plots would have provided misleading information.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation
    § Background

    In many studies, the reasons for believing a particular strategy would address a particular determinant were not explained.

    “but in many studies the reasons for believing a particular strategy would address a particular determinant were not explained.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Bosch 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Sensitivity analysis

    Sensitivity analyses in the meta-regression assumed a larger clustering effect than in the standard analyses by using higher ICC estimates taken from Campbell.

    “In the meta‐regression analyses, we carried out sensitivity analyses assuming a larger clustering effect than had been accounted for in the standard analyses, by using higher ICC estimates (i.e. the reported upper quartile range values) taken from Campbell (Campbell 2005).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Campbell 2005 source

      Not checked in the free run.

  • May combine two claims.

    Premisecitation
    § Methods

    Campbell et al extracted 220 ICCs from 21 data sets and reported the results separately for both primary and secondary care settings.

    “Campbell et al extracted 220 ICCs from 21 data sets and reported the results separately for both primary and secondary care settings.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Campbell 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.

    Interpretationreasoning
    § Background

    There may be additional evidence on the effectiveness of tailoring or on how it can be undertaken most effectively.

    “Consequently, there may be additional evidence on the effectiveness of tailoring or on how it can be undertaken most effectively.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationown data
    § Authors' conclusions

    Tailored implementation can be effective, but the effect is variable and tends to be small to moderate.

    “Tailored implementation can be effective, but the effect is variable and tends to be small to moderate.”
    • Also stated in: § Plain language summary · plain
      “The findings continue to indicate that tailored interventions can change professional practice, although they are not always effective and, when they are, the effect is small to moderate.”
    • Also stated in: § Discussion · plain
      “Tailored implementation can be effective, but the effect is variable and tends to be small to moderate.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Strategies to address determinants may be selected in different ways.

    “Once determinants have been identified and those to be addressed have been chosen, strategies to address them have to be selected, but this process may be undertaken in different ways (Wensing 2014).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Wensing 2014 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Interpretationreasoning

    It is possible that use of interventions such as audit with feedback or educational outreach would have improved professional practice whether or not tailoring had been undertaken.

    “it is possible that use of such interventions (for example, audit with feedback, educational outreach) would have improved professional practice whether or not tailoring had been undertaken.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    If several methods are used together, a large number of determinants may be identified.

    “if several methods are used together, a large number of determinants may be identified (Krause 2014a)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Krause 2014a

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    Avorn 1992 had an unclear overall risk of bias.

    “Risk of bias overall Unclear risk 5 criteria unclear risk”
    Quote in the paperNot a substantial claim
  • The quote only partly states this claim.

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    For interventions tailored to address identified determinants of practice compared to no intervention, the certainty of evidence for implementation of recommended practice is moderate (3) for cluster-RCTs.

    “Outcome: Implementation of recommended practice, e.g. clinical practice guideline recommendations 17 (7 studies included in meta‐regression) Cluster‐RCTs (4) Borderline risk of bias (‐0.5) Inconsistency between studies, and between outcomes within studies (‐0.5) No serious indirectness No serious imprecision None 3”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Study design and conductreasoning
    § Potential biases in the review process

    Using a complex search, including a sensitive RCT filter, in key electronic databases should have identified the majority of relevant, published trials.

    “Using a complex search, including a sensitive RCT filter, in the key electronic databases should have identified the majority of relevant, published trials.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    The overall risk of bias for Foy 2004 was unclear (4 criteria unclear risk, including randomisation and allocation concealment).

    “Risk of bias overall Unclear risk 4 criteria unclear risk, including randomisation and allocation concealment”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Foy 2004 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    Avorn 1983 had an unclear overall risk of bias.

    “Risk of bias overall Unclear risk 5 criteria unclear risk”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    Adjustments at the level of the cluster could potentially improve the intervention effect.

    “Whether adjustment was made for local factors New In some studies, adjustments were made at the level of the cluster (clinical team, hospital), and these adjustments could potentially improve the intervention effect Add”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Determinants may be classified in different ways.

    “Determinants may be classified in different ways (Légaré 2009).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Légaré 2009

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S4 (based). May combine two claims.

    Interpretationnone given
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    Theories of human behaviour potentially help explain why a determinant affects practice and indicate which interventions are most likely to address the determinants.

    “Use of a theory when developing an intervention In analysis Theories of human behaviour potentially help explain why a determinant affects practice and indicate which interventions are most likely to address the determinants Keep”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductown data
    § Potential biases in the review process

    The meta-regression pooled a relatively wide variety of outcomes, but in all studies the outcomes related to processes of care and addressed the same question about effectiveness of tailored interventions.

    “We pooled a relatively wide variety of outcomes in the meta‐regression analysis, although in all studies the study outcomes related to processes of care, and the studies all addressed the same question about the effectiveness of tailored interventions.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationreasoning

    The economic costs of tailoring may be higher than several other interventions because identification of determinants and tailoring involve additional steps.

    “Since the identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy, such as education alone, the economic costs of tailoring may be higher than several other interventions.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: The identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    The overall risk of bias for Flottorp 2002 was unclear.

    “Risk of bias overall Unclear risk Allocation concealment”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Flottorp 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    The overall risk of bias for Callahan 1994 was unclear (5 criteria unclear risk).

    “Risk of bias overall Unclear risk 5 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Callahan 1994 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    The overall risk of bias for Engers 2005 was unclear (4 criteria unclear risk).

    “Risk of bias overall Unclear risk 4 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Engers 2005 source

      Not checked in the free run.

  • May combine two claims.

    Interpretationreasoning
    § Potential biases in the review process

    This risk is more likely to be a source of bias for reviews that include interrupted time series and controlled before-after studies, because randomised trials are more likely to be identified through electronic database searches.

    “However, this is more likely to be a source of bias for reviews in which interrupted time series and controlled before‐after studies are included, since in comparison with these types of studies, randomised trials are more likely to be identified through electronic database searches.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).

    Interpretationreasoning

    The economic costs of tailoring may be lower than other interventions by enabling more expensive elements to be reserved for situations when they are likely to be effective.

    “Conversely, they may be lower through enabling the more expensive elements of interventions to be reserved for situations when they are likely to be effective.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Study design and conductreasoning
    § Potential biases in the review process

    In the meta-regression analysis, the outcomes included were either those reported as the primary outcome or, when this was not possible, the most clinically relevant measure, and therefore the introduction of bias is unlikely.

    “In the meta‐regression analysis, the outcomes included were either those reported as the primary outcome or, when this was not possible, we selected the most clinically relevant measure and therefore the introduction of bias is unlikely.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Determinants may be investigated by various methods.

    “Determinants may be investigated by various methods”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Krause 2014a

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, contamination was at low risk of bias.

    “Contamination Low risk Randomisation at nursing home level”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Information not provided”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk 2 intervention nursing homes withdrew during the study, and 1 control home was excluded as no influenza vaccination was offered during the study period”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data collection done by medical abstractors but it is not clear if they were blinded”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk Follow‐up of 85% of patients achieved”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk A randomised block design was used, but the method for generating the randomisation sequence was not described”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 1 high risk and 5 unclear risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, blinding of outcome assessment was at low risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Low risk The vaccinating professional recorded the vaccination on a website”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk Details not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, contamination was at unclear risk of bias.

    “Contamination Unclear risk Practices were randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, baseline outcomes were at unclear risk of bias.

    “Baseline outcomes Unclear risk The baseline outcomes were similar, except for onset to drug treatment within 180 minutes; not clear if this was adjusted for”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk No loss to follow‐up after randomisation”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, allocation concealment was at high risk of bias.

    “Allocation concealment (selection bias) High risk Allocation was not undertaken independently”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, incomplete outcome data was at unclear risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Unclear risk It is not clear why the mean number of charts reviewed is lower than the 45 planned for; some charts were not available at post intervention data collection”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Baseline characteristics comparable”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 unclear risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data were collected from patient charts and it is not clear whether the data collectors were blinded”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Details not clear.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 1 high risk, 5 unclear risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk Only 1 hospital withdrew after randomisation”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Patient characteristics were similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, baseline characteristics were at unclear risk of bias.

    “Baseline characteristics Unclear risk Baseline patient characteristics comparable other than age, BP, and smoking prevalence in 1 group, but not clear whether adjusted for”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes were similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, contamination was at low risk of bias.

    “Contamination Low risk Hospitals randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Lakshminarayan 2010, other bias was at low risk of bias.

    “Other bias Low risk Low likelihood of contamination; baseline characteristics of patients similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Lakshminarayan 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Leviton 1999, contamination was at low risk of bias.

    “Contamination Low risk The hospital was the unit of randomisation”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Leviton 1999 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, contamination was at low risk of bias.

    “Contamination Low risk Practice groups randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Langham 2002, other bias was at unclear risk of bias.

    “Other bias Unclear risk Baseline patients' characteristics broadly similar; practices were in a single locality and contamination may have been possible”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Langham 2002

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Karuza 1995, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk No patient differences between study groups”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Karuza 1995 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk Data were collected from patient records by a research nurse”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, contamination was at low risk of bias.

    “Contamination Low risk Pharmacies stratified by geographical location prior to randomisation”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes comparable”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk Data were collected from all pharmacies in the study”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, other bias was at unclear risk of bias.

    “Other bias Unclear risk There are no baseline performance data; the risk of contamination is unclear”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Characteristics of hospitals and professionals similar at baseline, although there was an uneven distribution of patients with heart failure, but there was adjustment”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Unable to assess”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, other bias was at unclear risk of bias.

    “Other bias Unclear risk Contamination may have been possible, since geographically related practices were randomised to intervention and control groups. Patient characteristics were similar in both groups”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, contamination was at low risk of bias.

    “Contamination Low risk Groups of geographically related practices were randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 2 unclear risk criteria (1 allocation concealment)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, baseline characteristics were at unclear risk of bias.

    “Baseline characteristics Unclear risk Baseline characteristics not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Looijmans 2010, other bias was at low risk of bias.

    “Other bias Low risk Comparable baseline characteristics in the study groups; contamination unlikely”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Looijmans 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk Coin toss was used to assign hospitals to intervention or control groups”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, contamination was at low risk of bias.

    “Contamination Low risk Randomisation at the level of the district”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, contamination was at low risk of bias.

    “Contamination Low risk Randomisation at general practice level”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk No differences at baseline”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 unclear risk, 1 high risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, other bias was at low risk of bias.

    “Other bias Low risk Baseline characteristics similar; low likelihood of contamination”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, other bias was at unclear risk of bias.

    “Other bias Unclear risk Contamination is unlikely; baseline characteristics of the health centres are not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Process not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk There were baseline differences in some outcomes, but adjusted for”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Intervention and control groups comparable”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Details not provided”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, random sequence generation was at low risk of bias.

    “Random sequence generation (selection bias) Low risk A computer random number function was used”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, baseline characteristics were at unclear risk of bias.

    “Baseline characteristics Unclear risk There were no differences in patient characteristics between study groups. No data on clinicians”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Matchar 2002, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk Whether or not the data abstractors were blinded is not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Matchar 2002 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Murphy 2009, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 3 unclear risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Murphy 2009 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Ross‐Degnan 1996, baseline characteristics were at unclear risk of bias.

    “Baseline characteristics Unclear risk Baseline characteristics not reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Ross‐Degnan 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Santoso 1996, blinding of participants and personnel was at unclear risk of bias.

    “Blinding of participants and personnel (performance bias) All outcomes Unclear risk It would not have been possible to blind staff of the study health centres to the intervention group”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Santoso 1996 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, allocation concealment was at low risk of bias.

    “Allocation concealment (selection bias) Low risk Allocation was undertaken by an independent researcher”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, other bias was at low risk of bias.

    “Other bias Low risk Low risk of contamination”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, other bias was at unclear risk of bias.

    “Other bias Unclear risk The study took place in a single health maintenance organisation and contamination may be a risk. Baseline adherence was higher than national figures”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk It is not clear whether the data collectors were blind to study groups”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk No practices withdrew”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk More physicians in the control group were male. Otherwise, patient and physician characteristics were similar between groups (adjusted for)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, other bias was at low risk of bias.

    “Other bias Low risk Contamination unlikely; baseline characteristics similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk Intention‐to‐treat analysis; all included hospitals completed the study”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Patient characteristics comparable except for education and macrovascular complications (adjusted for)”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk No details given”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, other bias was at low risk of bias.

    “Other bias Low risk Baseline patient characteristics were similar. Contamination unlikely”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, contamination was at low risk of bias.

    “Contamination Low risk Randomisation at the hospital level”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 unclear risk criteria”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk A random number table was used”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, contamination was at low risk of bias.

    “Contamination Low risk Practices were randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, baseline outcomes were at low risk of bias.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Characteristics similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, baseline outcomes were at unclear risk of bias.

    “Baseline outcomes Unclear risk No baseline data”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk Method not described”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, random sequence generation was at unclear risk of bias.

    “Random sequence generation (selection bias) Unclear risk Method of sequence generation not described”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk There is no information on blinding of data collection”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, contamination was at low risk of bias.

    “Contamination Low risk Hospitals randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Scott 2013, allocation concealment was at low risk of bias.

    “Allocation concealment (selection bias) Low risk Allocation was undertaken by a data management centre independent of the researchers”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Scott 2013 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, blinding of outcome assessment was at unclear risk of bias.

    “Blinding of outcome assessment (detection bias) All outcomes Unclear risk It is not clear if the data collectors were blinded”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Soumerai 1998, baseline characteristics were at low risk of bias.

    “Baseline characteristics Low risk Patient characteristics were similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Soumerai 1998 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Schouten 2007, incomplete outcome data was at low risk of bias.

    “Incomplete outcome data (attrition bias) All outcomes Low risk All hospitals completed the study”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Schouten 2007

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Simon 2005, allocation concealment was at unclear risk of bias.

    “Allocation concealment (selection bias) Unclear risk No details given”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Simon 2005 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of detection bias was judged low because data were based on a patient-completed questionnaire.

    “Blinding of outcome assessment (detection bias) All outcomes Low risk Symptom questionnaire completed by patients”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of detection bias from blinding of outcome assessment was judged unclear.

    “Blinding of outcome assessment (detection bias) 
All outcomes Unclear risk It is not clear if data collectors were blind to study group.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of bias from baseline outcomes was judged low because baseline outcomes were similar.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT in nursing homes and hospitals, the risk of selection bias from random sequence generation was judged unclear.

    “Random sequence generation (selection bias) Unclear risk”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of attrition bias was judged low because adequate follow-up was achieved.

    “Incomplete outcome data (attrition bias) 
All outcomes Low risk Adequate follow‐up achieved”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of selection bias from allocation concealment was judged unclear because details were not reported.

    “Allocation concealment (selection bias) Unclear risk Details not reported”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, contamination was at low risk of bias.

    “Contamination Low risk General practices were randomised”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of contamination bias was judged low because randomisation was at general practice level.

    “Contamination Low risk Randomised at general practice level”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of bias from baseline outcomes was judged low because baseline outcomes were similar.

    “Baseline outcomes Low risk Baseline outcomes similar”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, other bias was at low risk of bias.

    “Other bias Low risk Baseline characteristics similar; low likelihood of contamination”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the overall risk of bias was judged unclear because 5 criteria were at unclear risk.

    “Risk of bias overall Unclear risk 5 unclear risk criteria”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, selective reporting was at low risk of bias.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of bias from baseline characteristics was judged low because baseline characteristics were comparable.

    “Baseline characteristics Low risk Baseline characteristics comparable”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of performance bias was judged low because data were based on a questionnaire completed by patients.

    “Blinding of participants and personnel (performance bias) 
All outcomes Low risk Data were based on a questionnaire completed by patients”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In van Bruggen 2008, overall risk of bias was unclear.

    “Risk of bias overall Unclear risk 4 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites van Bruggen 2008 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the overall risk of bias was judged unclear because 2 criteria were at unclear risk.

    “Risk of bias overall Unclear risk 2 criteria unclear risk”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductreasoning
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of other bias was judged unclear because contamination across wards could have occurred.

    “Other bias Unclear risk Quote:”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of selection bias from allocation concealment was judged unclear because the method of allocation was not described.

    “Allocation concealment (selection bias) Unclear risk Method of allocation not described”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of bias from baseline characteristics was judged low because baseline characteristics were similar.

    “Baseline characteristics Low risk Baseline characteristics similar”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of attrition bias was judged low because over 84% of patients in each study group provided data.

    “Incomplete outcome data (attrition bias) 
All outcomes Low risk Over 84% of patients in each study group provided data”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Classified as probably not a substantial claim.

    Premisecitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the previous review (Baker 2010), Bayesian and classical analyses produced similar results.

    “In the previous review (Baker 2010), we included a Bayesian analysis as well as a classical analysis, but since these approaches produced similar results, we used only the classical analysis in this review.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Baker 2010 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of performance bias from blinding of participants and personnel was judged unclear because nurses could not be blinded to study group.

    “Blinding of participants and personnel (performance bias) 
All outcomes Unclear risk Nurses could not be blinded to study group”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of other bias was judged low because practitioners and patients were generally similar and randomisation by practice reduced the risk of contamination.

    “Other bias Low risk Generally similar practitioners and patients in study and control groups; randomised by practice, reducing the risk of contamination”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of selection bias from random sequence generation was judged low because a computer-generated list of random numbers was used.

    “Random sequence generation (selection bias) Low risk Quote:”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In Zwarenstein 2007, the risk of reporting bias was judged unclear because there was no information on adherence to recommended practice.

    “Selective reporting (reporting bias) Unclear risk No information on adherence to recommended practice”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Zwarenstein 2007 source

      Not checked in the free run.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data
    § Query Results ( S1 or S3 or S7 ) AND ( S48 or S39 ) [March 2013] Limiters ‐ Published Date from: 20130101‐20130321 35 S52 ( S1 or S3 or S7 ) AND ( S48 or S39 ) Limiters ‐ Published Date from: 20091001‐20121231 [December 2012] 709 S51 S34 AND ( TI random* or AB random* ) Limiters ‐ Published Date from: 20091001‐20121231 232 S50 ( S34 and S39 ) NOT S49 Limiters ‐ Published Date from: 20091001‐20121231 132 S49 S34 and S48 Limiters ‐ Published Date from: 20091001‐20121231 275 S48 S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 137,865 S47 TI controlled AND TI ( trial or trials or study or experiment* or intervention ) 15,931 S46 AB ( (multicent* n2 design*) or (multicent* n2 study) or (multicent* n2 studies) or (multicent* n2 trial*) ) or AB ( (multi‐cent* n2 design*) or (multi‐cent* n2 study) or (multi‐cent* n2 studies) or (multi‐cent* n2 trial*) ) 5,903 S45 TI multicentre or multicenter or multi‐centre or multi‐center 3,900 S44 TI ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) OR AB ( cluster N2 trial* or cluster N2 study or cluster N2 group or cluster N2 groups or cluster N2 cohort or cluster N2 design or cluster N2 experiment* ) 1,454 S43 TI ( control group or control groups OR control* experiment* or control* design or controlled study ) OR AB ( control group OR control groups or control* cohort* or controlled experiment* controlled design or controlled study) 44,895 S42 TI random* or AB random* 98,033 S41 TI ( “clinical study” or “clinical studies” ) or AB ( “clinical study” or “clinical studies” ) 6,327 S40 (MM "Clinical Trials+") 7,551 S39 S35 OR S36 OR S37 OR S38 13,003 S38 TI improve management 455 S37 TI ( (professional practice or professional practices) ) OR AB ( (professional practice or professional practices) ) 7,215 S36 TI ( ((practice or practices or medication) N2 pattern#) ) OR AB ( ((practice or practices or medication) N2 pattern#) ) 1,497 S35 TI ( multicentre or multicenter or multi‐centre or multi‐center ) 3,864 S34 S32 AND S33 6,770 S33 ( MN "Health Personnel+" or MH "Nursing+" or MH "medicine+" or MH "family practice" ) OR TI ( (physician# or nurse or nurses or nursing or practitioner# or (primary N2 care) or provider# or therapist# or counsellor#) ) OR TI ( (care or therapy or management or health) ) OR MW ( (care or therapy or management or health) ) OR TI ( (clinical or medical or medicine or physician#) ) OR MW ( (clinical or medical or medicine or physician#) ) 1,624,839 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 OR S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 7,918 S31 MM "education, continuing" AND MH quality of health care 18 S30 ( TI (feedback) or AB (feedback) ) AND MH "Education, Continuing+" 167 S29 TI (guideline# and adherence) 363 S28 ( MH "education, medical, continuing" or MH "education, nursing, continuing" or MH "refresher courses" OR clinical clerkship OR education, dental, continuing OR education, pharmacy, continuing ) AND ( TI ( ((improve# or improving or improvement#) N2 (care or service or services)) ) OR AB ( ((improve# or improving or improvement#) N2 (care or service or services)) ) ) 234 S27 TI (improve N2 "use") 138 S26 TI "appropriate drug use" OR AB "appropriate drug use" 6 S25 TI ( (appropriate prescribing or optimal prescribing) ) OR AB ( (appropriate prescribing or optimal prescribing) ) 225 S24 TI ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) OR AB ( ((suboptimal* or sub‐optimal*) N2 (drug# or medication# or prescribing or care)) ) 254 S23 TI (barrier# and evidence‐based) 108 S22 ( ( MH "guideline adherence" or TI (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) OR ( MH "guideline adherence" or AB (guideline N2 (adher* or implement* or compliance or comply* or impact)) ) ) AND TI ( (difficult* or failure or problem# or barrier# or faciltator# or enabler#) ) 171 S21 TI ( (motivat* N2 (practitioner# or physician# or provider#)) ) OR AB ( (motivat* N2 (practitioner# or physician# or provider#)) ) 158 S20 AB (practice pattern# N3 (change# or changing or improv*)) 115 S19 AB (practice pattern# N3 (impact or influenc* or implement* or effect or effectiveness)) 52 S18 TI Practice pattern# 485 S17 TI (barrier# and (guideline# or implement*)) 257 S16 AB (barrier# N3 (guideline# or implement*)) 1,029 S15 TI (barrier# and (facilitator# or enabler# or professional# or physician# or practitioner# or provider#)) 745 S14 TI ( (practitioner# resistance or physician# Resistance) ) OR AB ( (practitioner# resistance or physician# Resistance) ) 120 S13 TI (barrier# and delivery) 35 S12 TI opinion leader# OR AB opinion leader# 248 S11 TI ( ((GP or gp's) N2 barrier#) ) OR AB ( ((GP or gp's) N2 barrier#) ) 7 S10 TI (encourage N2 ("use" or prescribing)) 35 S9 TI Educational outreach OR AB Educational outreach 137 S8 TI ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) OR AB ( (target* N2 (clinician# or doctor# or nurse# or nursing or pharmacist# or physician# or practitioner# or prescriber# or provider#)) ) 876 S7 TI ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) OR AB ( (target* N2 intervention# N3 (doctor# or "health care professional#" or "health* professional#" or nurse# or nursing or physician# or practice# or practitioner# or provider#)) ) 182 S6 TI ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) OR AB ( ((nurse or nurses or pharmacist# or prescriber#) N2 feedback) ) 157 S5 TI ( ((prescriber# or physician# or practitioner#) N3 feedback) ) OR AB ( ((prescriber# or physician# or practitioner#) N3 feedback) ) 197 S4 TI ((influence# or influencing) and (implement* or uptake)) 100 S3 TI ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) OR AB ( (tailor* N4 (physician# or practitioner# or doctor# or practice or nurse or nurses or service or services or hospital)) ) 492 S2 AB (tailor* N2 (intervention# or strategy or strategies)) 1,382 S1 TI (tailor* and (intervention# or strategy or strategies)) 255

    In the Dutch cluster-RCT, the risk of reporting bias was judged low because appropriate outcomes were reported.

    “Selective reporting (reporting bias) Low risk Appropriate outcomes reported”
    Quote in the paperNot a substantial claim
205 of 205
  • The paper relies on this without support.

    Tailored intervention strategies are frequently recommended among approaches to implementation of improvement in health professional performance.

    “Tailored intervention strategies are frequently recommended among approaches to the implementation of improvement in health professional performance.”
  • The paper relies on this without support.

    The determinants of practice may vary in different healthcare settings, groups of healthcare professionals, or clinical tasks.

    “The determinants may vary in different healthcare settings, groups of healthcare professionals, or clinical tasks.”
  • The paper relies on this without support.

    The mRCT includes randomised trial records held on the National Institutes of Health ClinicalTrials.gov website.

    “As the mRCT includes randomised trial records held on the National Institutes of Health (NIH) ClinicalTrials.gov website (available at: http://clinicaltrials.gov/), we did not search the latter registry.”
  • The paper relies on this without support.

    The identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy.

    “Since the identification of determinants and tailoring of strategies involve additional steps beyond the application of a particular strategy, such as education alone”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Systematic reviews of interventions designed to change professional practice have shown only small numbers of rigorous evaluations reporting the use of theory to assess implementation problems or guide intervention design.

    “Despite this, systematic reviews of interventions designed to change professional practice have shown only small numbers of rigorous evaluations reporting the use of theory to assess implementation problems or guide intervention design [8,13,14].”
  • No specific method for identifying and prioritizing determinants and selecting implementation strategies has been proven superior.

    “and no specific method has been proven superior (37).”
  • Strategies are not always well-matched to the contexts in which they are deployed, including the interventions to be implemented, settings, stakeholder preferences, and implementation determinants.

    “Consequently, strategies are not always well-matched to the contexts in which they are deployed, including the interventions to be implemented, settings, stakeholder preferences, and implementation determinants (37, 42, 54).”
  • In the systematic review of 32 studies, the methods used to identify and prioritize determinants and select implementation strategies were not often well-described.

    “however, the methods used to identify and prioritize determinants and select implementation strategies were not often well-described”
  • The evidence regarding the superiority of multifaceted and tailored implementation strategies to single-component strategies has been mixed.

    “While the use of multifaceted and tailored implementation strategies is intuitive and has considerable face validity (29), the evidence regarding their superiority to single-component strategies has been mixed (37, 39, 40).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • Cheater 2006 point estimate falls outside its confidence interval

    Minor

    The reported estimate of −2.3 is below the lower bound of its stated 95% confidence interval, −1.63.

  • Risk-of-bias categories account for only 31 studies

    Minor

    The reported categories contain 4 high-risk, 21 unclear-risk, and 6 low-risk studies, totaling 31 rather than the 32 included studies.

    Reported 32 · recomputed 31

  • Footnote gives 14 rather than 17 studies outside the meta-regression

    Minor

    The summary-of-findings text says 17 studies were not included in the meta-regression, but its footnote says 14.

  • Sensitivity analysis changes the no-intervention subgroup from seven to eight studies

    Minor

    The main subgroup analysis identifies seven studies whose control group received no intervention. The sensitivity-analysis paragraph describes the corresponding subgroup as eight studies.

  • Callahan 1994 is high risk in the table but omitted from the high-risk count

    Minor

    The risk-of-bias summary names four high-risk studies, whereas the study-results table also labels Callahan 1994 high risk.

  • Reported minimum follow-up odds ratio exceeds a table value

    Minor

    The text gives 1.08 as the lowest follow-up odds ratio among the 15 studies, but Table 3 reports 1.07 for Coenen 2004.

6 of 6

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Samsa, 1998, A seven step model for practice improvement research: description and application to the managing anticoagulation services trial, New Medicine, 2, 139
  2. Fretheim, 2004, Improving prescribing of antihypertensive and cholesterol-lowering drugs: a method for identifying and addressing barriers to change, BMC Health Services Research, 4, 23, 10.1186/1472-6963-4-23 · DOI · Paper page
  3. Murphy, 2005, The SPHERE study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses, Current Controlled Trials in Cardiovascular Medicine, 6, 11, 10.1186/1468-6708-6-11 · DOI
  4. Cochrane Effective Practice and Organisation of Care Group: Data Collection Checklist EPOC resources for review authors (http://www.epoc.cochrane.org/en/handsearchers.html) Revised 2002
  5. Cochrane Effective Practice and Organisation of Care Group, 2014, What outcomes should be reported in EPOC reviews?
  6. Institute for Clinical Effectiveness and Health Policy Early Review Organizing Software (EROS) 2009
  7. Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org
  8. Lomas, 1994, Teaching old (and not so old) dogs new tricks: effective ways to implement research findings, 1
  9. Légaré, 2009, Assessing barriers and facilitators to knowledge use, 83

Cited by

Sorted by citations

Authors
Baker, R., Camosso-Stefinovic, J., Gillies, C., Shaw, E. J., Cheater, F., Flottorp, S., Robertson, N., Wensing, M., Fiander, M., Eccles, M. P., Godycki-Cwirko, M., van Lieshout, J., & Jäger, C.
Affiliations
  • University of Leicester (GB)
  • Information Specialist, Consultant; Carl-Zeiss-Str. 37 Munich Bayern Germany D-85521
  • National Institute for Health and Care Excellence (GB)
  • University of East Anglia (GB)
  • Nasjonalt Kunnskapssenter for Helsetjenesten (NO)
  • Radboud University Medical Center (NL)
  • Information Specialist, Consultant; Ottawa Ontario Canada
  • Newcastle University (GB)
  • Medical University of Lodz; Centre for Family and Community Medicine; Kopcindkiego 20 Lodz Poland 90-153
  • Radboud University Medical Center; Scientific Institute for Quality of Healthcare; P.O.Box 9101 Nijmegen Netherlands 6500 HB
  • University Hospital Heidelberg (DE)
Venue
Cochrane Database of Systematic Reviews
Publisher
Wiley
Published
2015-04-29
Volume
2015
Issue
4
Pages
CD005470-CD005470
ISSN
  • 1361-6137 (ISSN-L)
  • 1465-1858
OpenAlex
W1579988526
Cited by
711
References
222
Citations by year
2026: 33 · 2025: 81 · 2024: 91 · 2023: 88 · 2022: 83 · 2021: 75 · 2020: 60 · 2019: 57 · 2018: 48 · 2017: 48 · 2016: 27 · 2015: 16 · 2013: 1 · 2012: 1
FWCI
8.40
Type
journal article
Language
en
Open access
Locations
  • Cochrane Database of Systematic Reviews (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Health Professions › General Health Professions › Health Sciences Research and Education
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
personalized interventions, implementation strategies, health care outcomes, theory-based intervention, risk of bias, nursing practice, primary care practices, quality improvement, meta-regression, risk of bias assessment, risk of bias adjustment
MeSH terms
Humans, Outcome and Process Assessment, Health Care, Professional Practice, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review